<p>To remove any residual drug within the vaginal lumen prior to HSV-2 challenge in the safety studies, vaginal washes were obtained with 100 µl of saline. The vaginal washes were tested in a viral plaque assay. Results are means (SEM) from 2 independent experiments with pooled washes from 5 mice each; the asterisk denotes p<0.05.</p
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
Background Several active ingredients proposed as vaginal microbicides have been shown paradoxically...
<p>(<b>A</b>). Survival curves for mice pretreated with a single dose of each blinded gel or no gel ...
Despite significant protection in preclinical studies, cellulose sulfate (CS) failed to protect wome...
<p>Mice were treated daily for seven days with microbicides and twelve hours after the final applica...
<p>Animals described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.004671...
<p>Mice were challenged with ∼10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</sup> pfu/mouse of HSV-2(46...
<p>Mice were treated with 2 mg medoxyprogesterone 7 and 3 days prior to vaginal HSV-2 challenge. On ...
BACKGROUND: Microbicides must protect against STD pathogens without causing unacceptable toxic effec...
<p>A) Depo-treated (vaginal) or untreated (anorectal) Balb/C mice were challenged with 10<sup>6</sup...
Abstract Background Microbicides must protect against STD pathogens without causing unacceptable tox...
<p>A) HSV-2 enhancement model. Balb/C mice (n = 40 per group) were depo-treated 7 d before starting ...
The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This noti...
<p>A group of female RAG1<sup>−/−</sup> mice (n = 4–5) were immunized intra-vaginally with TK<sup>−/...
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
Background Several active ingredients proposed as vaginal microbicides have been shown paradoxically...
<p>(<b>A</b>). Survival curves for mice pretreated with a single dose of each blinded gel or no gel ...
Despite significant protection in preclinical studies, cellulose sulfate (CS) failed to protect wome...
<p>Mice were treated daily for seven days with microbicides and twelve hours after the final applica...
<p>Animals described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.004671...
<p>Mice were challenged with ∼10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</sup> pfu/mouse of HSV-2(46...
<p>Mice were treated with 2 mg medoxyprogesterone 7 and 3 days prior to vaginal HSV-2 challenge. On ...
BACKGROUND: Microbicides must protect against STD pathogens without causing unacceptable toxic effec...
<p>A) Depo-treated (vaginal) or untreated (anorectal) Balb/C mice were challenged with 10<sup>6</sup...
Abstract Background Microbicides must protect against STD pathogens without causing unacceptable tox...
<p>A) HSV-2 enhancement model. Balb/C mice (n = 40 per group) were depo-treated 7 d before starting ...
The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This noti...
<p>A group of female RAG1<sup>−/−</sup> mice (n = 4–5) were immunized intra-vaginally with TK<sup>−/...
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
Background Several active ingredients proposed as vaginal microbicides have been shown paradoxically...